GlassScriptPhysician profile
Gregory J Mackay
NPI 1386686491
$7,176.01
in general payments reported to CMS, 2019-2025
17 companies · $895 in 2025
The $895 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,283 · 2020: $830 · 2021: $1,151 · 2022: $631 · 2023: $596 · 2024: $790 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,281.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $3,131.26 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $1,789.26 | 2019-2022 | |
| Abbvie INC. | $906.70 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $615.97 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $144.24 | 2021 | |
| Integra Lifesciences Corporation | $118.48 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Tela Bio, INC. | $91.14 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $60.45 | 2019-2021 | |
| Kls-Martin L.P. | $53.98 | 2023 | |
| Revance Therapeutics, INC. | $51.17 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $45.16 | 2021-2024 | |
| Acelrx Pharmaceuticals, INC. | $41.36 | 2021 | |
| Smith+Nephew, INC. | $31.81 | 2022-2023 | Pico 7, Acticoat 4" X 4", Pico 14 |
| Kerecis Limited | $29.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $26.44 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $23.97 | 2023 | Exparel, Iovera |
| Access Pro Medical, LLC | $15.06 | 2025 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mackay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.